Mustang Bio, Inc.

2 Gansevoort Street, 9th floor
New York
New York
10014
United States

Tel: 781-652-4500

Email: info@mustangbio.com

Show jobs for this employer

About Mustang Bio, Inc.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies based on the ground breaking Chimeric Antigen Receptor (CAR) research of Dr. Stephen Forman and Dr. Christine Brown of City of Hope, an NCI-designated Comprehensive Cancer Center. Mustang was formed to help bring this pioneering CAR research to as many patients as possible. Mustang, through a research agreement with COH, will develop CARs across multiple cancers, including for AML and Brain Cancer. Both of the lead programs are in phase I clinical trials.
YEAR FOUNDED:
2015
LEADERSHIP:
CEO: Manuel Litchman
CFO: David Horin
CLINICAL TRIAL:
Please click here for clinical trial information.

53 articles with Mustang Bio, Inc.